Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial. Lancet Oncol. 2011 Dec; 12(13):1222-8.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Antineoplastic Agents
Benzamides
Disease-Free Survival
Drug Administration Schedule
Female
Histone Deacetylase Inhibitors
Hodgkin Disease
Humans
Kaplan-Meier Estimate
Male
Middle Aged
North America
Pyrimidines
Recurrence
Time Factors
Treatment Outcome
Young Adult